nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—SLC9A1—nephron—kidney cancer	0.0345	0.126	CbGeAlD
Amiloride—PLAU—nephron—kidney cancer	0.0327	0.119	CbGeAlD
Amiloride—SLC22A2—nephron—kidney cancer	0.0155	0.0564	CbGeAlD
Amiloride—AOC1—nephron tubule—kidney cancer	0.00777	0.0284	CbGeAlD
Amiloride—SLC9A1—nephron tubule—kidney cancer	0.00744	0.0272	CbGeAlD
Amiloride—SCNN1G—renal system—kidney cancer	0.00719	0.0263	CbGeAlD
Amiloride—AOC1—renal system—kidney cancer	0.00706	0.0258	CbGeAlD
Amiloride—PLAU—nephron tubule—kidney cancer	0.00705	0.0257	CbGeAlD
Amiloride—SCNN1G—kidney—kidney cancer	0.00695	0.0254	CbGeAlD
Amiloride—AOC1—kidney—kidney cancer	0.00683	0.0249	CbGeAlD
Amiloride—SCNN1G—cortex of kidney—kidney cancer	0.00677	0.0247	CbGeAlD
Amiloride—SLC9A1—renal system—kidney cancer	0.00676	0.0247	CbGeAlD
Amiloride—AOC1—cortex of kidney—kidney cancer	0.00665	0.0243	CbGeAlD
Amiloride—SLC9A1—kidney—kidney cancer	0.00654	0.0239	CbGeAlD
Amiloride—SCNN1D—gonad—kidney cancer	0.00645	0.0235	CbGeAlD
Amiloride—PLAU—renal system—kidney cancer	0.00641	0.0234	CbGeAlD
Amiloride—SLC9A1—cortex of kidney—kidney cancer	0.00637	0.0232	CbGeAlD
Amiloride—PLAU—kidney—kidney cancer	0.0062	0.0226	CbGeAlD
Amiloride—SCNN1A—nephron tubule—kidney cancer	0.00618	0.0225	CbGeAlD
Amiloride—SCNN1B—renal system—kidney cancer	0.00608	0.0222	CbGeAlD
Amiloride—SLC9A1—cardiac atrium—kidney cancer	0.00606	0.0221	CbGeAlD
Amiloride—PLAU—cortex of kidney—kidney cancer	0.00604	0.022	CbGeAlD
Amiloride—SCNN1B—kidney—kidney cancer	0.00588	0.0214	CbGeAlD
Amiloride—PLAU—cardiac atrium—kidney cancer	0.00574	0.021	CbGeAlD
Amiloride—SCNN1B—cortex of kidney—kidney cancer	0.00572	0.0209	CbGeAlD
Amiloride—SCNN1A—renal system—kidney cancer	0.00562	0.0205	CbGeAlD
Amiloride—SCNN1B—gonad—kidney cancer	0.00545	0.0199	CbGeAlD
Amiloride—SCNN1A—kidney—kidney cancer	0.00543	0.0198	CbGeAlD
Amiloride—SCNN1A—cortex of kidney—kidney cancer	0.00529	0.0193	CbGeAlD
Amiloride—SLC22A2—nephron tubule—kidney cancer	0.00334	0.0122	CbGeAlD
Amiloride—SLC22A2—renal system—kidney cancer	0.00303	0.0111	CbGeAlD
Amiloride—SLC22A2—kidney—kidney cancer	0.00293	0.0107	CbGeAlD
Amiloride—SLC22A2—cortex of kidney—kidney cancer	0.00286	0.0104	CbGeAlD
Amiloride—SLC22A4—nephron tubule—kidney cancer	0.00247	0.00903	CbGeAlD
Amiloride—SLC22A4—renal system—kidney cancer	0.00225	0.00821	CbGeAlD
Amiloride—SLC22A4—kidney—kidney cancer	0.00217	0.00794	CbGeAlD
Amiloride—SLC22A1—renal system—kidney cancer	0.00214	0.00782	CbGeAlD
Amiloride—SLC22A4—cortex of kidney—kidney cancer	0.00212	0.00773	CbGeAlD
Amiloride—SLC22A1—kidney—kidney cancer	0.00207	0.00756	CbGeAlD
Amiloride—Decreased appetite—Sorafenib—kidney cancer	0.000533	0.00141	CcSEcCtD
Amiloride—Anorexia—Dactinomycin—kidney cancer	0.000532	0.00141	CcSEcCtD
Amiloride—Nausea—Pazopanib—kidney cancer	0.000531	0.00141	CcSEcCtD
Amiloride—Paraesthesia—Sunitinib—kidney cancer	0.000529	0.0014	CcSEcCtD
Amiloride—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000529	0.0014	CcSEcCtD
Amiloride—Fatigue—Sorafenib—kidney cancer	0.000528	0.0014	CcSEcCtD
Amiloride—Dyspnoea—Sunitinib—kidney cancer	0.000526	0.00139	CcSEcCtD
Amiloride—Pain—Sorafenib—kidney cancer	0.000524	0.00139	CcSEcCtD
Amiloride—Constipation—Sorafenib—kidney cancer	0.000524	0.00139	CcSEcCtD
Amiloride—Tinnitus—Paclitaxel—kidney cancer	0.00052	0.00138	CcSEcCtD
Amiloride—Dyspepsia—Sunitinib—kidney cancer	0.000519	0.00137	CcSEcCtD
Amiloride—Decreased appetite—Sunitinib—kidney cancer	0.000512	0.00136	CcSEcCtD
Amiloride—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000509	0.00135	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000508	0.00135	CcSEcCtD
Amiloride—Asthenia—Vinblastine—kidney cancer	0.000508	0.00135	CcSEcCtD
Amiloride—Fatigue—Sunitinib—kidney cancer	0.000508	0.00134	CcSEcCtD
Amiloride—Depression—Capecitabine—kidney cancer	0.000508	0.00134	CcSEcCtD
Amiloride—Asthenia—Everolimus—kidney cancer	0.000506	0.00134	CcSEcCtD
Amiloride—Cough—Gemcitabine—kidney cancer	0.000506	0.00134	CcSEcCtD
Amiloride—Pain—Sunitinib—kidney cancer	0.000504	0.00133	CcSEcCtD
Amiloride—Constipation—Sunitinib—kidney cancer	0.000504	0.00133	CcSEcCtD
Amiloride—Gastrointestinal pain—Sorafenib—kidney cancer	0.000501	0.00133	CcSEcCtD
Amiloride—Pruritus—Everolimus—kidney cancer	0.000499	0.00132	CcSEcCtD
Amiloride—Jaundice—Capecitabine—kidney cancer	0.000497	0.00131	CcSEcCtD
Amiloride—Arthralgia—Gemcitabine—kidney cancer	0.000493	0.00131	CcSEcCtD
Amiloride—Chest pain—Gemcitabine—kidney cancer	0.000493	0.00131	CcSEcCtD
Amiloride—Alopecia—Paclitaxel—kidney cancer	0.000493	0.0013	CcSEcCtD
Amiloride—Asthenia—Erlotinib—kidney cancer	0.000489	0.00129	CcSEcCtD
Amiloride—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000488	0.00129	CcSEcCtD
Amiloride—Decreased appetite—Dactinomycin—kidney cancer	0.000485	0.00128	CcSEcCtD
Amiloride—Diarrhoea—Vinblastine—kidney cancer	0.000485	0.00128	CcSEcCtD
Amiloride—Abdominal pain—Sorafenib—kidney cancer	0.000484	0.00128	CcSEcCtD
Amiloride—Diarrhoea—Everolimus—kidney cancer	0.000483	0.00128	CcSEcCtD
Amiloride—Gastrointestinal pain—Sunitinib—kidney cancer	0.000482	0.00128	CcSEcCtD
Amiloride—Pruritus—Erlotinib—kidney cancer	0.000482	0.00127	CcSEcCtD
Amiloride—Fatigue—Dactinomycin—kidney cancer	0.000481	0.00127	CcSEcCtD
Amiloride—Flatulence—Paclitaxel—kidney cancer	0.000478	0.00127	CcSEcCtD
Amiloride—Pain—Dactinomycin—kidney cancer	0.000477	0.00126	CcSEcCtD
Amiloride—Tension—Paclitaxel—kidney cancer	0.000476	0.00126	CcSEcCtD
Amiloride—Anorexia—Vincristine—kidney cancer	0.000475	0.00126	CcSEcCtD
Amiloride—Nervousness—Paclitaxel—kidney cancer	0.000471	0.00125	CcSEcCtD
Amiloride—Back pain—Paclitaxel—kidney cancer	0.000469	0.00124	CcSEcCtD
Amiloride—Dizziness—Vinblastine—kidney cancer	0.000469	0.00124	CcSEcCtD
Amiloride—Dizziness—Everolimus—kidney cancer	0.000467	0.00124	CcSEcCtD
Amiloride—Muscle spasms—Paclitaxel—kidney cancer	0.000467	0.00123	CcSEcCtD
Amiloride—Abdominal pain—Sunitinib—kidney cancer	0.000466	0.00123	CcSEcCtD
Amiloride—Diarrhoea—Erlotinib—kidney cancer	0.000466	0.00123	CcSEcCtD
Amiloride—Bradycardia—Capecitabine—kidney cancer	0.000466	0.00123	CcSEcCtD
Amiloride—Feeling abnormal—Dactinomycin—kidney cancer	0.00046	0.00122	CcSEcCtD
Amiloride—Haemoglobin—Capecitabine—kidney cancer	0.00046	0.00122	CcSEcCtD
Amiloride—Haemorrhage—Capecitabine—kidney cancer	0.000457	0.00121	CcSEcCtD
Amiloride—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000456	0.00121	CcSEcCtD
Amiloride—Tremor—Paclitaxel—kidney cancer	0.000455	0.0012	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000454	0.0012	CcSEcCtD
Amiloride—Insomnia—Vincristine—kidney cancer	0.000451	0.00119	CcSEcCtD
Amiloride—Anorexia—Gemcitabine—kidney cancer	0.000451	0.00119	CcSEcCtD
Amiloride—Vomiting—Vinblastine—kidney cancer	0.000451	0.00119	CcSEcCtD
Amiloride—Dizziness—Erlotinib—kidney cancer	0.00045	0.00119	CcSEcCtD
Amiloride—Vomiting—Everolimus—kidney cancer	0.000449	0.00119	CcSEcCtD
Amiloride—Paraesthesia—Vincristine—kidney cancer	0.000448	0.00118	CcSEcCtD
Amiloride—Rash—Everolimus—kidney cancer	0.000445	0.00118	CcSEcCtD
Amiloride—Dermatitis—Everolimus—kidney cancer	0.000445	0.00118	CcSEcCtD
Amiloride—Headache—Vinblastine—kidney cancer	0.000444	0.00117	CcSEcCtD
Amiloride—Headache—Everolimus—kidney cancer	0.000442	0.00117	CcSEcCtD
Amiloride—Abdominal pain—Dactinomycin—kidney cancer	0.000441	0.00117	CcSEcCtD
Amiloride—Visual impairment—Capecitabine—kidney cancer	0.000441	0.00117	CcSEcCtD
Amiloride—Asthenia—Sorafenib—kidney cancer	0.00044	0.00116	CcSEcCtD
Amiloride—Vertigo—Paclitaxel—kidney cancer	0.000436	0.00115	CcSEcCtD
Amiloride—Decreased appetite—Vincristine—kidney cancer	0.000433	0.00115	CcSEcCtD
Amiloride—Pruritus—Sorafenib—kidney cancer	0.000433	0.00115	CcSEcCtD
Amiloride—Vomiting—Erlotinib—kidney cancer	0.000433	0.00115	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000431	0.00114	CcSEcCtD
Amiloride—Gastrointestinal disorder—Vincristine—kidney cancer	0.00043	0.00114	CcSEcCtD
Amiloride—Fatigue—Vincristine—kidney cancer	0.00043	0.00114	CcSEcCtD
Amiloride—Rash—Erlotinib—kidney cancer	0.000429	0.00114	CcSEcCtD
Amiloride—Dermatitis—Erlotinib—kidney cancer	0.000429	0.00114	CcSEcCtD
Amiloride—Palpitations—Paclitaxel—kidney cancer	0.000429	0.00113	CcSEcCtD
Amiloride—Hyponatraemia—Doxorubicin—kidney cancer	0.000428	0.00113	CcSEcCtD
Amiloride—Insomnia—Gemcitabine—kidney cancer	0.000428	0.00113	CcSEcCtD
Amiloride—Headache—Erlotinib—kidney cancer	0.000427	0.00113	CcSEcCtD
Amiloride—Tinnitus—Capecitabine—kidney cancer	0.000427	0.00113	CcSEcCtD
Amiloride—Constipation—Vincristine—kidney cancer	0.000426	0.00113	CcSEcCtD
Amiloride—Pain—Vincristine—kidney cancer	0.000426	0.00113	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000426	0.00113	CcSEcCtD
Amiloride—Pain in extremity—Doxorubicin—kidney cancer	0.000426	0.00113	CcSEcCtD
Amiloride—Paraesthesia—Gemcitabine—kidney cancer	0.000425	0.00112	CcSEcCtD
Amiloride—Cough—Paclitaxel—kidney cancer	0.000423	0.00112	CcSEcCtD
Amiloride—Asthenia—Sunitinib—kidney cancer	0.000423	0.00112	CcSEcCtD
Amiloride—Dyspnoea—Gemcitabine—kidney cancer	0.000422	0.00112	CcSEcCtD
Amiloride—Nausea—Vinblastine—kidney cancer	0.000421	0.00111	CcSEcCtD
Amiloride—Somnolence—Gemcitabine—kidney cancer	0.000421	0.00111	CcSEcCtD
Amiloride—Nausea—Everolimus—kidney cancer	0.000419	0.00111	CcSEcCtD
Amiloride—Diarrhoea—Sorafenib—kidney cancer	0.000419	0.00111	CcSEcCtD
Amiloride—Pruritus—Sunitinib—kidney cancer	0.000417	0.0011	CcSEcCtD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000414	0.00119	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000414	0.00119	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000414	0.00119	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000414	0.00119	CbGpPWpGaD
Amiloride—Chest pain—Paclitaxel—kidney cancer	0.000413	0.00109	CcSEcCtD
Amiloride—Arthralgia—Paclitaxel—kidney cancer	0.000413	0.00109	CcSEcCtD
Amiloride—SLC9A1—Disease—AMER1—kidney cancer	0.000412	0.00118	CbGpPWpGaD
Amiloride—Decreased appetite—Gemcitabine—kidney cancer	0.000411	0.00109	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—CDKN1B—kidney cancer	0.00041	0.00118	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000408	0.00108	CcSEcCtD
Amiloride—Fatigue—Gemcitabine—kidney cancer	0.000408	0.00108	CcSEcCtD
Amiloride—Gastrointestinal pain—Vincristine—kidney cancer	0.000408	0.00108	CcSEcCtD
Amiloride—SLC9A1—Metabolism—PDHB—kidney cancer	0.000406	0.00117	CbGpPWpGaD
Amiloride—Dizziness—Sorafenib—kidney cancer	0.000405	0.00107	CcSEcCtD
Amiloride—Pain—Gemcitabine—kidney cancer	0.000405	0.00107	CcSEcCtD
Amiloride—Constipation—Gemcitabine—kidney cancer	0.000405	0.00107	CcSEcCtD
Amiloride—Nausea—Erlotinib—kidney cancer	0.000405	0.00107	CcSEcCtD
Amiloride—Alopecia—Capecitabine—kidney cancer	0.000404	0.00107	CcSEcCtD
Amiloride—PLAU—Hemostasis—GRB7—kidney cancer	0.000404	0.00116	CbGpPWpGaD
Amiloride—Diarrhoea—Sunitinib—kidney cancer	0.000403	0.00107	CcSEcCtD
Amiloride—Asthenia—Dactinomycin—kidney cancer	0.0004	0.00106	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—CCND1—kidney cancer	0.0004	0.00115	CbGpPWpGaD
Amiloride—Confusional state—Paclitaxel—kidney cancer	0.000399	0.00106	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—JUN—kidney cancer	0.000399	0.00115	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CDKN1B—kidney cancer	0.000397	0.00114	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—CTNNB1—kidney cancer	0.000396	0.00114	CbGpPWpGaD
Amiloride—Abdominal pain—Vincristine—kidney cancer	0.000394	0.00104	CcSEcCtD
Amiloride—Flatulence—Capecitabine—kidney cancer	0.000392	0.00104	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—JUN—kidney cancer	0.00039	0.00112	CbGpPWpGaD
Amiloride—Dizziness—Sunitinib—kidney cancer	0.00039	0.00103	CcSEcCtD
Amiloride—Feeling abnormal—Gemcitabine—kidney cancer	0.00039	0.00103	CcSEcCtD
Amiloride—Shock—Paclitaxel—kidney cancer	0.00039	0.00103	CcSEcCtD
Amiloride—Vomiting—Sorafenib—kidney cancer	0.00039	0.00103	CcSEcCtD
Amiloride—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000389	0.00103	CcSEcCtD
Amiloride—Rash—Sorafenib—kidney cancer	0.000386	0.00102	CcSEcCtD
Amiloride—Dermatitis—Sorafenib—kidney cancer	0.000386	0.00102	CcSEcCtD
Amiloride—Back pain—Capecitabine—kidney cancer	0.000385	0.00102	CcSEcCtD
Amiloride—Headache—Sorafenib—kidney cancer	0.000384	0.00102	CcSEcCtD
Amiloride—Muscle spasms—Capecitabine—kidney cancer	0.000383	0.00101	CcSEcCtD
Amiloride—SLC9A1—Metabolism—CCBL1—kidney cancer	0.000382	0.0011	CbGpPWpGaD
Amiloride—Diarrhoea—Dactinomycin—kidney cancer	0.000382	0.00101	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CCND1—kidney cancer	0.000379	0.00109	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—JUN—kidney cancer	0.000378	0.00109	CbGpPWpGaD
Amiloride—Anorexia—Paclitaxel—kidney cancer	0.000378	0.000999	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—PTEN—kidney cancer	0.000377	0.00108	CbGpPWpGaD
Amiloride—Muscular weakness—Doxorubicin—kidney cancer	0.000376	0.000995	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CTNNB1—kidney cancer	0.000375	0.00108	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ITPR2—kidney cancer	0.000375	0.00108	CbGpPWpGaD
Amiloride—Vomiting—Sunitinib—kidney cancer	0.000375	0.000992	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—RAF1—kidney cancer	0.000375	0.00108	CbGpPWpGaD
Amiloride—Tremor—Capecitabine—kidney cancer	0.000373	0.000987	CcSEcCtD
Amiloride—Rash—Sunitinib—kidney cancer	0.000372	0.000984	CcSEcCtD
Amiloride—Dermatitis—Sunitinib—kidney cancer	0.000371	0.000983	CcSEcCtD
Amiloride—Abdominal distension—Doxorubicin—kidney cancer	0.000371	0.000981	CcSEcCtD
Amiloride—Headache—Sunitinib—kidney cancer	0.000369	0.000977	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PTEN—kidney cancer	0.000366	0.00105	CbGpPWpGaD
Amiloride—Nausea—Sorafenib—kidney cancer	0.000364	0.000963	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000361	0.000955	CcSEcCtD
Amiloride—Angina pectoris—Doxorubicin—kidney cancer	0.000359	0.00095	CcSEcCtD
Amiloride—Insomnia—Paclitaxel—kidney cancer	0.000358	0.000948	CcSEcCtD
Amiloride—Vertigo—Capecitabine—kidney cancer	0.000358	0.000947	CcSEcCtD
Amiloride—Asthenia—Vincristine—kidney cancer	0.000358	0.000947	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—MAPK3—kidney cancer	0.000357	0.00103	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—TP53—kidney cancer	0.000356	0.00102	CbGpPWpGaD
Amiloride—Paraesthesia—Paclitaxel—kidney cancer	0.000356	0.000941	CcSEcCtD
Amiloride—Vomiting—Dactinomycin—kidney cancer	0.000355	0.000939	CcSEcCtD
Amiloride—SLC9A1—G Protein Signaling Pathways—KRAS—kidney cancer	0.000354	0.00102	CbGpPWpGaD
Amiloride—Dyspnoea—Paclitaxel—kidney cancer	0.000353	0.000934	CcSEcCtD
Amiloride—Somnolence—Paclitaxel—kidney cancer	0.000352	0.000932	CcSEcCtD
Amiloride—Palpitations—Capecitabine—kidney cancer	0.000352	0.000931	CcSEcCtD
Amiloride—Rash—Dactinomycin—kidney cancer	0.000352	0.000931	CcSEcCtD
Amiloride—Nausea—Sunitinib—kidney cancer	0.00035	0.000927	CcSEcCtD
Amiloride—Dyspepsia—Paclitaxel—kidney cancer	0.000349	0.000923	CcSEcCtD
Amiloride—Cough—Capecitabine—kidney cancer	0.000348	0.00092	CcSEcCtD
Amiloride—SLC9A1—Disease—GPC3—kidney cancer	0.000346	0.000993	CbGpPWpGaD
Amiloride—Neutropenia—Doxorubicin—kidney cancer	0.000345	0.000912	CcSEcCtD
Amiloride—Dysuria—Doxorubicin—kidney cancer	0.000345	0.000912	CcSEcCtD
Amiloride—Decreased appetite—Paclitaxel—kidney cancer	0.000344	0.000911	CcSEcCtD
Amiloride—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000342	0.000905	CcSEcCtD
Amiloride—Fatigue—Paclitaxel—kidney cancer	0.000341	0.000904	CcSEcCtD
Amiloride—Diarrhoea—Vincristine—kidney cancer	0.000341	0.000903	CcSEcCtD
Amiloride—Pollakiuria—Doxorubicin—kidney cancer	0.00034	0.000901	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—MAPK1—kidney cancer	0.00034	0.000976	CbGpPWpGaD
Amiloride—Asthenia—Gemcitabine—kidney cancer	0.000339	0.000898	CcSEcCtD
Amiloride—Chest pain—Capecitabine—kidney cancer	0.000339	0.000897	CcSEcCtD
Amiloride—Arthralgia—Capecitabine—kidney cancer	0.000339	0.000897	CcSEcCtD
Amiloride—Constipation—Paclitaxel—kidney cancer	0.000339	0.000896	CcSEcCtD
Amiloride—Pain—Paclitaxel—kidney cancer	0.000339	0.000896	CcSEcCtD
Amiloride—Pruritus—Gemcitabine—kidney cancer	0.000335	0.000886	CcSEcCtD
Amiloride—Nausea—Dactinomycin—kidney cancer	0.000332	0.000877	CcSEcCtD
Amiloride—SLC9A1—Metabolism—PPAT—kidney cancer	0.000331	0.000951	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GLIPR1—kidney cancer	0.000331	0.000951	CbGpPWpGaD
Amiloride—Dizziness—Vincristine—kidney cancer	0.00033	0.000873	CcSEcCtD
Amiloride—Confusional state—Capecitabine—kidney cancer	0.000328	0.000867	CcSEcCtD
Amiloride—ASIC1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000327	0.000939	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000327	0.000939	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000327	0.000939	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000327	0.000939	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000327	0.000939	CbGpPWpGaD
Amiloride—Feeling abnormal—Paclitaxel—kidney cancer	0.000326	0.000864	CcSEcCtD
Amiloride—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000324	0.000857	CcSEcCtD
Amiloride—Diarrhoea—Gemcitabine—kidney cancer	0.000324	0.000856	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—KRAS—kidney cancer	0.000321	0.000922	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—MYC—kidney cancer	0.000321	0.000921	CbGpPWpGaD
Amiloride—Jaundice—Doxorubicin—kidney cancer	0.00032	0.000847	CcSEcCtD
Amiloride—SLC9A1—Disease—ST3GAL2—kidney cancer	0.00032	0.000919	CbGpPWpGaD
Amiloride—Shock—Capecitabine—kidney cancer	0.00032	0.000846	CcSEcCtD
Amiloride—Vomiting—Vincristine—kidney cancer	0.000317	0.000839	CcSEcCtD
Amiloride—Rash—Vincristine—kidney cancer	0.000314	0.000832	CcSEcCtD
Amiloride—Dermatitis—Vincristine—kidney cancer	0.000314	0.000831	CcSEcCtD
Amiloride—Abdominal pain—Paclitaxel—kidney cancer	0.000313	0.000828	CcSEcCtD
Amiloride—Headache—Vincristine—kidney cancer	0.000312	0.000827	CcSEcCtD
Amiloride—Anorexia—Capecitabine—kidney cancer	0.00031	0.00082	CcSEcCtD
Amiloride—SLC9A1—Metabolism—APRT—kidney cancer	0.000308	0.000884	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—FH—kidney cancer	0.000308	0.000884	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—MAPK1—kidney cancer	0.000307	0.000881	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—MYC—kidney cancer	0.000304	0.000874	CbGpPWpGaD
Amiloride—Vomiting—Gemcitabine—kidney cancer	0.000301	0.000796	CcSEcCtD
Amiloride—Bradycardia—Doxorubicin—kidney cancer	0.0003	0.000794	CcSEcCtD
Amiloride—SLC9A1—Disease—SLC5A3—kidney cancer	0.0003	0.000861	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PGK1—kidney cancer	0.0003	0.000861	CbGpPWpGaD
Amiloride—Rash—Gemcitabine—kidney cancer	0.000298	0.000789	CcSEcCtD
Amiloride—Dermatitis—Gemcitabine—kidney cancer	0.000298	0.000789	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—MAPK1—kidney cancer	0.000298	0.000855	CbGpPWpGaD
Amiloride—Haemoglobin—Doxorubicin—kidney cancer	0.000296	0.000784	CcSEcCtD
Amiloride—Headache—Gemcitabine—kidney cancer	0.000296	0.000784	CcSEcCtD
Amiloride—Nausea—Vincristine—kidney cancer	0.000296	0.000784	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000296	0.000784	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—PIK3CA—kidney cancer	0.000295	0.000847	CbGpPWpGaD
Amiloride—Haemorrhage—Doxorubicin—kidney cancer	0.000295	0.00078	CcSEcCtD
Amiloride—Insomnia—Capecitabine—kidney cancer	0.000294	0.000778	CcSEcCtD
Amiloride—SLC9A1—Disease—LDHB—kidney cancer	0.000294	0.000844	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SFRP2—kidney cancer	0.000294	0.000844	CbGpPWpGaD
Amiloride—Paraesthesia—Capecitabine—kidney cancer	0.000292	0.000772	CcSEcCtD
Amiloride—Dyspnoea—Capecitabine—kidney cancer	0.00029	0.000767	CcSEcCtD
Amiloride—SLC9A1—Metabolism—GPC3—kidney cancer	0.000289	0.000831	CbGpPWpGaD
Amiloride—Dyspepsia—Capecitabine—kidney cancer	0.000286	0.000757	CcSEcCtD
Amiloride—Visual impairment—Doxorubicin—kidney cancer	0.000284	0.000752	CcSEcCtD
Amiloride—Asthenia—Paclitaxel—kidney cancer	0.000284	0.000752	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000283	0.000812	CbGpPWpGaD
Amiloride—Decreased appetite—Capecitabine—kidney cancer	0.000283	0.000748	CcSEcCtD
Amiloride—SLC9A1—Metabolism—CA2—kidney cancer	0.000282	0.000809	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—KRAS—kidney cancer	0.000281	0.000807	CbGpPWpGaD
Amiloride—Nausea—Gemcitabine—kidney cancer	0.000281	0.000744	CcSEcCtD
Amiloride—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000281	0.000743	CcSEcCtD
Amiloride—Fatigue—Capecitabine—kidney cancer	0.00028	0.000741	CcSEcCtD
Amiloride—Pruritus—Paclitaxel—kidney cancer	0.00028	0.000741	CcSEcCtD
Amiloride—Constipation—Capecitabine—kidney cancer	0.000278	0.000735	CcSEcCtD
Amiloride—Pain—Capecitabine—kidney cancer	0.000278	0.000735	CcSEcCtD
Amiloride—PLAU—Hemostasis—IFNA1—kidney cancer	0.000275	0.000791	CbGpPWpGaD
Amiloride—Tinnitus—Doxorubicin—kidney cancer	0.000275	0.000728	CcSEcCtD
Amiloride—SLC9A1—Metabolism—ALAD—kidney cancer	0.000274	0.000788	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TCEB2—kidney cancer	0.000274	0.000787	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TCEB1—kidney cancer	0.000274	0.000787	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000273	0.000784	CbGpPWpGaD
Amiloride—Diarrhoea—Paclitaxel—kidney cancer	0.000271	0.000717	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—MAPK3—kidney cancer	0.00027	0.000775	CbGpPWpGaD
Amiloride—Feeling abnormal—Capecitabine—kidney cancer	0.000268	0.000709	CcSEcCtD
Amiloride—SLC9A1—Metabolism—ST3GAL2—kidney cancer	0.000268	0.000769	CbGpPWpGaD
Amiloride—Gastrointestinal pain—Capecitabine—kidney cancer	0.000266	0.000703	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—TP53—kidney cancer	0.000263	0.000757	CbGpPWpGaD
Amiloride—Dizziness—Paclitaxel—kidney cancer	0.000262	0.000693	CcSEcCtD
Amiloride—SLC9A1—Metabolism—ALDH1A1—kidney cancer	0.000262	0.000752	CbGpPWpGaD
Amiloride—Alopecia—Doxorubicin—kidney cancer	0.000261	0.00069	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PIK3CA—kidney cancer	0.000258	0.000742	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TP53—kidney cancer	0.000257	0.000739	CbGpPWpGaD
Amiloride—Abdominal pain—Capecitabine—kidney cancer	0.000257	0.00068	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—MAPK1—kidney cancer	0.000257	0.000738	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IFNA2—kidney cancer	0.000256	0.000736	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000254	0.000731	CbGpPWpGaD
Amiloride—Flatulence—Doxorubicin—kidney cancer	0.000253	0.000669	CcSEcCtD
Amiloride—Tension—Doxorubicin—kidney cancer	0.000252	0.000667	CcSEcCtD
Amiloride—Vomiting—Paclitaxel—kidney cancer	0.000252	0.000666	CcSEcCtD
Amiloride—SLC9A1—Metabolism—SLC5A3—kidney cancer	0.000251	0.000721	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PGK1—kidney cancer	0.000251	0.000721	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TP53—kidney cancer	0.00025	0.000717	CbGpPWpGaD
Amiloride—Rash—Paclitaxel—kidney cancer	0.00025	0.000661	CcSEcCtD
Amiloride—Dermatitis—Paclitaxel—kidney cancer	0.000249	0.00066	CcSEcCtD
Amiloride—Nervousness—Doxorubicin—kidney cancer	0.000249	0.00066	CcSEcCtD
Amiloride—Back pain—Doxorubicin—kidney cancer	0.000248	0.000657	CcSEcCtD
Amiloride—Headache—Paclitaxel—kidney cancer	0.000248	0.000657	CcSEcCtD
Amiloride—Muscle spasms—Doxorubicin—kidney cancer	0.000247	0.000653	CcSEcCtD
Amiloride—SLC9A1—Metabolism—LDHB—kidney cancer	0.000246	0.000707	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000246	0.000706	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000245	0.000704	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000245	0.000704	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000245	0.000704	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000244	0.000701	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—KRAS—kidney cancer	0.000243	0.000697	CbGpPWpGaD
Amiloride—Nausea—Paclitaxel—kidney cancer	0.000235	0.000623	CcSEcCtD
Amiloride—Asthenia—Capecitabine—kidney cancer	0.000233	0.000617	CcSEcCtD
Amiloride—PLAU—Hemostasis—IGF2—kidney cancer	0.000231	0.000663	CbGpPWpGaD
Amiloride—Vertigo—Doxorubicin—kidney cancer	0.000231	0.00061	CcSEcCtD
Amiloride—Pruritus—Capecitabine—kidney cancer	0.00023	0.000608	CcSEcCtD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000228	0.000656	CbGpPWpGaD
Amiloride—Palpitations—Doxorubicin—kidney cancer	0.000227	0.0006	CcSEcCtD
Amiloride—Cough—Doxorubicin—kidney cancer	0.000224	0.000593	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—PIK3CA—kidney cancer	0.000223	0.00064	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RPL14—kidney cancer	0.000223	0.00064	CbGpPWpGaD
Amiloride—Diarrhoea—Capecitabine—kidney cancer	0.000222	0.000588	CcSEcCtD
Amiloride—Chest pain—Doxorubicin—kidney cancer	0.000219	0.000578	CcSEcCtD
Amiloride—Arthralgia—Doxorubicin—kidney cancer	0.000219	0.000578	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000215	0.000619	CbGpPWpGaD
Amiloride—Dizziness—Capecitabine—kidney cancer	0.000215	0.000569	CcSEcCtD
Amiloride—SLC9A1—Metabolism—CA9—kidney cancer	0.000213	0.000613	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000213	0.000611	CbGpPWpGaD
Amiloride—Confusional state—Doxorubicin—kidney cancer	0.000211	0.000559	CcSEcCtD
Amiloride—Vomiting—Capecitabine—kidney cancer	0.000207	0.000547	CcSEcCtD
Amiloride—Shock—Doxorubicin—kidney cancer	0.000206	0.000545	CcSEcCtD
Amiloride—Rash—Capecitabine—kidney cancer	0.000205	0.000542	CcSEcCtD
Amiloride—Dermatitis—Capecitabine—kidney cancer	0.000205	0.000542	CcSEcCtD
Amiloride—Headache—Capecitabine—kidney cancer	0.000204	0.000539	CcSEcCtD
Amiloride—SLC22A2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000202	0.00058	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ITPR2—kidney cancer	0.000201	0.000579	CbGpPWpGaD
Amiloride—Anorexia—Doxorubicin—kidney cancer	0.0002	0.000528	CcSEcCtD
Amiloride—Nausea—Capecitabine—kidney cancer	0.000193	0.000511	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000191	0.000505	CcSEcCtD
Amiloride—Insomnia—Doxorubicin—kidney cancer	0.000189	0.000501	CcSEcCtD
Amiloride—SLC22A1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000188	0.000541	CbGpPWpGaD
Amiloride—Paraesthesia—Doxorubicin—kidney cancer	0.000188	0.000498	CcSEcCtD
Amiloride—Dyspnoea—Doxorubicin—kidney cancer	0.000187	0.000494	CcSEcCtD
Amiloride—Somnolence—Doxorubicin—kidney cancer	0.000186	0.000493	CcSEcCtD
Amiloride—ASIC1—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000185	0.000531	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000185	0.000531	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000185	0.000531	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000185	0.000531	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000185	0.000531	CbGpPWpGaD
Amiloride—Dyspepsia—Doxorubicin—kidney cancer	0.000184	0.000488	CcSEcCtD
Amiloride—Decreased appetite—Doxorubicin—kidney cancer	0.000182	0.000482	CcSEcCtD
Amiloride—SLC9A1—Metabolism—CRABP1—kidney cancer	0.000181	0.000521	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000181	0.000479	CcSEcCtD
Amiloride—Fatigue—Doxorubicin—kidney cancer	0.000181	0.000478	CcSEcCtD
Amiloride—Constipation—Doxorubicin—kidney cancer	0.000179	0.000474	CcSEcCtD
Amiloride—Pain—Doxorubicin—kidney cancer	0.000179	0.000474	CcSEcCtD
Amiloride—SLC22A2—Neuronal System—KCNMA1—kidney cancer	0.000179	0.000513	CbGpPWpGaD
Amiloride—Feeling abnormal—Doxorubicin—kidney cancer	0.000173	0.000457	CcSEcCtD
Amiloride—SLC22A2—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000173	0.000496	CbGpPWpGaD
Amiloride—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000171	0.000453	CcSEcCtD
Amiloride—SLC9A1—Disease—PSMD7—kidney cancer	0.000169	0.000485	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ITPR2—kidney cancer	0.000169	0.000485	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—KCNMA1—kidney cancer	0.000167	0.000479	CbGpPWpGaD
Amiloride—Abdominal pain—Doxorubicin—kidney cancer	0.000166	0.000438	CcSEcCtD
Amiloride—SLC22A1—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000161	0.000462	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTT1—kidney cancer	0.000154	0.000442	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ACHE—kidney cancer	0.000154	0.000442	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SLC2A1—kidney cancer	0.000153	0.000438	CbGpPWpGaD
Amiloride—SLC9A1—Disease—JUNB—kidney cancer	0.000152	0.000435	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—BCHE—kidney cancer	0.00015	0.000432	CbGpPWpGaD
Amiloride—Asthenia—Doxorubicin—kidney cancer	0.00015	0.000398	CcSEcCtD
Amiloride—Pruritus—Doxorubicin—kidney cancer	0.000148	0.000392	CcSEcCtD
Amiloride—SLC9A1—Metabolism—SCARB1—kidney cancer	0.000146	0.000418	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTGS1—kidney cancer	0.000144	0.000414	CbGpPWpGaD
Amiloride—Diarrhoea—Doxorubicin—kidney cancer	0.000143	0.000379	CcSEcCtD
Amiloride—SLC9A1—Metabolism—PSMD7—kidney cancer	0.000141	0.000406	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—BCHE—kidney cancer	0.00014	0.000402	CbGpPWpGaD
Amiloride—Dizziness—Doxorubicin—kidney cancer	0.000139	0.000367	CcSEcCtD
Amiloride—SLC9A1—Metabolism—BCHE—kidney cancer	0.000134	0.000385	CbGpPWpGaD
Amiloride—Vomiting—Doxorubicin—kidney cancer	0.000133	0.000352	CcSEcCtD
Amiloride—SLC9A1—Metabolism—SLC5A5—kidney cancer	0.000132	0.00038	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—ACHE—kidney cancer	0.000132	0.00038	CbGpPWpGaD
Amiloride—Rash—Doxorubicin—kidney cancer	0.000132	0.00035	CcSEcCtD
Amiloride—Dermatitis—Doxorubicin—kidney cancer	0.000132	0.000349	CcSEcCtD
Amiloride—Headache—Doxorubicin—kidney cancer	0.000131	0.000347	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000129	0.000371	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SLC2A1—kidney cancer	0.000128	0.000367	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—RAF1—kidney cancer	0.000127	0.000365	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000125	0.000359	CbGpPWpGaD
Amiloride—Nausea—Doxorubicin—kidney cancer	0.000124	0.000329	CcSEcCtD
Amiloride—SLC9A1—Disease—CDKN2B—kidney cancer	0.000123	0.000354	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—ACHE—kidney cancer	0.000123	0.000354	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000122	0.00035	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.00012	0.000346	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000116	0.000334	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000116	0.000333	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000116	0.000333	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000116	0.000333	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—BCHE—kidney cancer	0.000115	0.000331	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IL2—kidney cancer	0.000114	0.000327	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000112	0.000322	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000108	0.000311	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000108	0.000311	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000108	0.000311	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000108	0.000311	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—BCHE—kidney cancer	0.000107	0.000308	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTP1—kidney cancer	0.000107	0.000306	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ACY1—kidney cancer	0.000103	0.000297	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ABCB1—kidney cancer	0.000101	0.00029	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ABCB1—kidney cancer	9.86e-05	0.000283	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HIF1A—kidney cancer	9.86e-05	0.000283	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TSC2—kidney cancer	9.84e-05	0.000283	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTM1—kidney cancer	9.8e-05	0.000281	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—VEGFA—kidney cancer	9.68e-05	0.000278	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ACY1—kidney cancer	9.64e-05	0.000277	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP1A1—kidney cancer	9.29e-05	0.000267	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MAPK3—kidney cancer	9.16e-05	0.000263	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PDHB—kidney cancer	8.79e-05	0.000253	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MAPK1—kidney cancer	8.71e-05	0.00025	CbGpPWpGaD
Amiloride—SLC9A1—Disease—KIT—kidney cancer	8.69e-05	0.00025	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APC—kidney cancer	8.69e-05	0.00025	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CCBL1—kidney cancer	8.27e-05	0.000237	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—KRAS—kidney cancer	8.23e-05	0.000236	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PDHB—kidney cancer	8.19e-05	0.000235	CbGpPWpGaD
Amiloride—SLC9A1—Disease—BRAF—kidney cancer	8.17e-05	0.000235	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CCBL1—kidney cancer	7.7e-05	0.000221	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—BRAF—kidney cancer	7.67e-05	0.00022	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CA—kidney cancer	7.56e-05	0.000217	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TP53—kidney cancer	7.31e-05	0.00021	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GLIPR1—kidney cancer	7.17e-05	0.000206	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPAT—kidney cancer	7.17e-05	0.000206	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—BRAF—kidney cancer	7.15e-05	0.000205	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—POMC—kidney cancer	6.93e-05	0.000199	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RAF1—kidney cancer	6.82e-05	0.000196	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ERBB2—kidney cancer	6.75e-05	0.000194	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPAT—kidney cancer	6.68e-05	0.000192	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GLIPR1—kidney cancer	6.68e-05	0.000192	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APRT—kidney cancer	6.66e-05	0.000191	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—FH—kidney cancer	6.66e-05	0.000191	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MTOR—kidney cancer	6.66e-05	0.000191	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CD4—kidney cancer	6.64e-05	0.000191	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTGS2—kidney cancer	6.6e-05	0.000189	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—RAF1—kidney cancer	6.41e-05	0.000184	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GPC3—kidney cancer	6.26e-05	0.00018	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN1B—kidney cancer	6.25e-05	0.000179	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APRT—kidney cancer	6.21e-05	0.000178	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—FH—kidney cancer	6.21e-05	0.000178	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	6.12e-05	0.000176	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CA2—kidney cancer	6.09e-05	0.000175	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—RAF1—kidney cancer	5.97e-05	0.000171	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALAD—kidney cancer	5.94e-05	0.000171	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.91e-05	0.00017	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CTNNB1—kidney cancer	5.9e-05	0.00017	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—BRAF—kidney cancer	5.88e-05	0.000169	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GPC3—kidney cancer	5.84e-05	0.000168	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ST3GAL2—kidney cancer	5.8e-05	0.000167	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTEN—kidney cancer	5.75e-05	0.000165	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.7e-05	0.000164	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CA2—kidney cancer	5.68e-05	0.000163	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALDH1A1—kidney cancer	5.67e-05	0.000163	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—RAF1—kidney cancer	5.58e-05	0.00016	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALAD—kidney cancer	5.54e-05	0.000159	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTGS2—kidney cancer	5.52e-05	0.000159	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.51e-05	0.000158	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—BRAF—kidney cancer	5.48e-05	0.000157	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PGK1—kidney cancer	5.43e-05	0.000156	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC5A3—kidney cancer	5.43e-05	0.000156	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ST3GAL2—kidney cancer	5.4e-05	0.000155	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LDHB—kidney cancer	5.33e-05	0.000153	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALDH1A1—kidney cancer	5.28e-05	0.000152	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC5A3—kidney cancer	5.06e-05	0.000145	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PGK1—kidney cancer	5.06e-05	0.000145	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LDHB—kidney cancer	4.96e-05	0.000143	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAPK3—kidney cancer	4.91e-05	0.000141	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—RAF1—kidney cancer	4.91e-05	0.000141	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTEN—kidney cancer	4.82e-05	0.000138	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MYC—kidney cancer	4.78e-05	0.000137	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAPK1—kidney cancer	4.68e-05	0.000134	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.66e-05	0.000134	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CA9—kidney cancer	4.62e-05	0.000133	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—RAF1—kidney cancer	4.57e-05	0.000131	CbGpPWpGaD
Amiloride—SLC9A1—Disease—KRAS—kidney cancer	4.42e-05	0.000127	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—MAPK1—kidney cancer	4.39e-05	0.000126	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.35e-05	0.000125	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CA9—kidney cancer	4.3e-05	0.000124	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—MAPK1—kidney cancer	4.09e-05	0.000118	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CA—kidney cancer	4.06e-05	0.000117	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CRABP1—kidney cancer	3.93e-05	0.000113	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CRABP1—kidney cancer	3.66e-05	0.000105	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ITPR2—kidney cancer	3.65e-05	0.000105	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ITPR2—kidney cancer	3.4e-05	9.77e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CA—kidney cancer	3.4e-05	9.76e-05	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—MAPK1—kidney cancer	3.37e-05	9.67e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ACHE—kidney cancer	3.33e-05	9.56e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTT1—kidney cancer	3.33e-05	9.56e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SCARB1—kidney cancer	3.15e-05	9.05e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—MAPK1—kidney cancer	3.14e-05	9.01e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS1—kidney cancer	3.12e-05	8.96e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ACHE—kidney cancer	3.1e-05	8.91e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTT1—kidney cancer	3.1e-05	8.91e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PSMD7—kidney cancer	3.06e-05	8.79e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SCARB1—kidney cancer	2.94e-05	8.44e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS1—kidney cancer	2.91e-05	8.35e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—BCHE—kidney cancer	2.9e-05	8.33e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC5A5—kidney cancer	2.86e-05	8.23e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PSMD7—kidney cancer	2.85e-05	8.19e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC2A1—kidney cancer	2.77e-05	7.95e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—BCHE—kidney cancer	2.7e-05	7.77e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC5A5—kidney cancer	2.67e-05	7.67e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.64e-05	7.58e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC2A1—kidney cancer	2.58e-05	7.41e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.46e-05	7.06e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTP1—kidney cancer	2.31e-05	6.63e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCB1—kidney cancer	2.18e-05	6.28e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTP1—kidney cancer	2.15e-05	6.18e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTM1—kidney cancer	2.12e-05	6.09e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCB1—kidney cancer	2.04e-05	5.85e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP1A1—kidney cancer	2.01e-05	5.77e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTM1—kidney cancer	1.98e-05	5.68e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP1A1—kidney cancer	1.87e-05	5.38e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—POMC—kidney cancer	1.5e-05	4.31e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—POMC—kidney cancer	1.4e-05	4.01e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS2—kidney cancer	1.2e-05	3.43e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS2—kidney cancer	1.11e-05	3.2e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTEN—kidney cancer	1.04e-05	3e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTEN—kidney cancer	9.72e-06	2.79e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CA—kidney cancer	7.36e-06	2.11e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CA—kidney cancer	6.86e-06	1.97e-05	CbGpPWpGaD
